Diagnosing Polyomavirus Nephropathy Without a Biopsy: Validation of the Urinary Polyomavirus-Haufen Test in a Proof-of-Concept Study Including Uromodulin Knockout Mice
The Journal of Infectious Diseases · 2024
DOI: 10.1093/infdis/jiae107 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift The Journal of Infectious Diseases, 2024. Verfasst von Volker Nickeleit und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, Division of Nephropathology, University of North Carolina School of Medicine at Chapel Hill, Chapel …. Hauptthemen laut MEDLINE: Uromodulin, Mice, Knockout, Kidney Diseases, Polyomavirus Infections. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Pathology and Laboratory Medicine, Division of Nephropathology, University of North Carolina.
Abstract (Originalsprache)
Background
Polyomavirus (PyV) nephropathy (PyVN) leads to kidney transplant dysfunction and loss. Since a definitive diagnosis requires an invasive kidney biopsy, a timely diagnosis is often hampered. In this clinical dilemma the PyV haufen-test, centering around the detection of 3-dimensional PyV aggregates in the urine, might provide crucial diagnostic information.
Methods
A multistep experimental design was used. The hypothesis was that PyV-haufen form within the kidneys under high concentrations of uromodulin, a kidney-specific protein and that PyV-haufen are, therefore, kidney-specific disease biomarkers.
Results
The first investigative step showed colocalization of uromodulin with aggregated PyV (1) in 10 kidneys with PyVN by immunohistochemistry, (2) in urine samples containing PyV-haufen by electron microscopy/immunogold labeling (n = 3), and (3) in urine samples containing PyV-haufen by immunoprecipitation assays (n = 4). In the in vitro experiments of the next step, only high uromodulin concentrations (≥1.25 mg/mL) aggregated PyV, as is expected to occur within injured nephrons. In contrast, in voided urine samples (n = 59) uromodulin concentrations were below aggregation concentrations (1.2−19.6 µg/mL). In the third investigative step, none of 11 uromodulin−/− knockout mice (0%) with histologic signs of PyVN showed urinary PyV-haufen shedding, compared with 10 of 14 uromodulin+/+ wild-type mice (71%).
Conclusions
PyV-haufen form within kidneys under high uromodulin concentrations. Thus, PyV-haufen detected in the urine are specific biomarkers for intrarenal disease (ie, definitive PyVN).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology and Laboratory Medicine, Division of Nephropathology, University of North Carolina School of Medicine at Chapel Hill, Chapel Hill, North Carolina, USA.
Förderung
- Department of Pathology and Laboratory Medicine
- Division of Nephropathology
- University of North Carolina
Zitieren
APA
Nickeleit, V., Butcher, D., Thompson, B. D., Rivier, L. H., & Singh, H. K. (2024). Diagnosing Polyomavirus Nephropathy Without a Biopsy: Validation of the Urinary Polyomavirus-Haufen Test in a Proof-of-Concept Study Including Uromodulin Knockout Mice. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiae107
Vancouver
Nickeleit V, Butcher D, Thompson BD, Rivier LH, Singh HK. Diagnosing Polyomavirus Nephropathy Without a Biopsy: Validation of the Urinary Polyomavirus-Haufen Test in a Proof-of-Concept Study Including Uromodulin Knockout Mice. The Journal of Infectious Diseases. 2024. doi:10.1093/infdis/jiae107
BibTeX
@article{Nickeleit2024,
author = {Nickeleit, Volker and Butcher, Dalton and Thompson, Bawana D and Rivier, Lauraine H and Singh, Harsharan K},
title = {Diagnosing Polyomavirus Nephropathy Without a Biopsy: Validation of the Urinary Polyomavirus-Haufen Test in a Proof-of-Concept Study Including Uromodulin Knockout Mice},
journal = {The Journal of Infectious Diseases},
year = {2024},
doi = {10.1093/infdis/jiae107}
}
EUVIMED